Reading the tape
NASDAQ: ECOR
electroCore, Inc.
Healthcare · Medical - Devices
Market Cap
$56.83M
52w High
$8.64
52w Low
$4.16
P/E
-4.03
Volume
74.73K
Outstanding Shares
8.08M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 6.03%Revenue (TTM): 27.2%FCF (TTM): -18.78%P/S: 11th pct
What changed
The stock rose 6.03% over the last year. Revenue grew 27.2% over the trailing twelve months. Operating margin moved from -48.3% to -41.06%. Free cash flow declined 18.78% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -41.06%. A decisive move in revenue — currently up 27.2% — would be the clearest signal to resolve the ambiguity.
Company profile
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies.
CEOThomas J. Errico
SectorHealthcare
IndustryMedical - Devices
Employees73
IPO dateJun 22, 2018
Valuation
Forward P/E—
EV/EBITDA-3.52
Enterprise value$40.46M
Stock splits
Feb 15, 2023↓ Reverse
Every 15 shares became 1
Profitability & growth
Revenue growth31.18%
Gross margin86.75%▲2.10%vs FY2024
Operating margin-41.06%▲14.98%vs FY2024
ROE817.2%▲618.68%vs FY2024
Analyst consensus
RatingBuy
Target price—
3
Buy
3
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est -$0.59 · Revenue est $9.01M
View